• EZ Cap™ Firefly Luciferase mRNA: Stable Reporter for mRNA As

  2026-07-28

  EZ Cap™ Firefly Luciferase mRNA provides a robust, Cap 1-optimized tool for gene regulation and in vivo bioluminescent assays. Its enhanced stability and translational efficiency enable reproducible quantification in mRNA delivery and translation efficiency studies. Designed for research, this product addresses key bottlenecks in molecular biology workflows.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-07-28

  This study identifies quercetin as a potent protective agent against cataract development, acting through modulation of the Hippo signaling pathway. By combining network pharmacology with in vivo and in vitro analyses, the research demonstrates that Hippo pathway inactivation by quercetin enhances lens epithelial cell survival and proliferation, providing a mechanistic basis for future pharmacological interventions.

• Differential Fgf10/Fgfr2 Expression Shapes Penile Developmen

  2026-07-27

  Wang and Zheng's 2025 study reveals that species-specific differences in penile development between guinea pigs and mice are governed by the differential expression of Shh, Fgf10, and Fgfr2. Their comparative analysis provides new mechanistic insight into urethral groove and prepuce formation, with implications for developmental biology and disease modeling.

• DNase I (RNase-free): Optimized DNA Removal for RNA Assays

  2026-07-27

  DNase I (RNase-free) from APExBIO is an essential tool for eliminating contaminating DNA in RNA extraction and RT-PCR, ensuring high-quality, reproducible results. Discover protocol enhancements, troubleshooting strategies, and translational insights inspired by cutting-edge cancer research.

• Gene Expression Profiling Predicts Olaparib Response in Meso

  2026-07-26

  Borchert et al. (2019) identified that gene expression signatures indicative of homologous recombination repair (HRR) deficiency—termed 'BRCAness'—correlate with increased susceptibility to PARP inhibitor therapy in malignant pleural mesothelioma (MPM) cell lines. Their findings provide a rationale for stratifying MPM patients by HRR status and inform the design of targeted combination therapies.

• Pemetrexed Disodium in Cancer Research: Protocols & Insights

  2026-07-25

  Pemetrexed, a multi-targeted antifolate antimetabolite, empowers cancer chemotherapy research with reproducible workflows and mechanistic precision. Discover advanced protocols, troubleshooting strategies, and novel insights for leveraging pemetrexed disodium in both in vitro and in vivo tumor models.

• Magnetite-Coated Cellulose Nanocrystals for Magnetic Hyperth

  2026-07-24

  This study systematically investigates how the surface chemistry of cellulose nanocrystals (CNCs) governs their interactions with magnetite nanoparticles and influences performance in magnetic hyperthermia. Findings reveal that CNC functionalization modulates nanocomposite structure, magnetization, and biocompatibility, providing a robust framework for designing safe and effective nanomaterials for biomedical applications.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-07-24

  This study uncovers how Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through the CUL3–MTDH ubiquitination pathway. The findings offer a mechanistic rationale for leveraging Gramine in ferroptosis and ubiquitination-focused cancer biology research workflows.

• Nifedipine (BAY-a-1040): Mechanisms, Evidence & Research Uti

  2026-07-23

  Nifedipine (BAY-a-1040) is a potent, selective L-type calcium channel blocker used in research to inhibit calcium influx and study calcium-dependent cellular processes. It also modulates iron metabolism and demonstrates antifungal effects. APExBIO provides high-purity, research-grade Nifedipine for advanced experimental workflows.

• Autopalmitoylation Regulates IDH1-R132H Activity in Cancer C

  2026-07-23

  This study uncovers autopalmitoylation at C269 as a unique regulatory mechanism of the oncogenic IDH1-R132H mutant, linking fatty acid metabolism to neomorphic enzyme activity in cancer. The findings highlight a newly druggable vulnerability in IDH1-mutant cancers and provide insight into metabolic-epigenetic crosstalk.

• Sodium Salicylate as a Precision NF-κB Inhibitor: Beyond Ass

  2026-07-22

  Explore how sodium salicylate, a potent NF-κB inhibitor, enables advanced inflammation and tumor microenvironment research. This article uncovers emerging mechanistic insights, protocol parameters, and translational impacts that set sodium salicylate apart.

• Berberine hydrochloride: Mechanisms and Gut-Bone Axis Eviden

  2026-07-22

  Berberine hydrochloride is a natural isoquinoline alkaloid with proven antibacterial and metabolic regulatory activities. It modulates the gut-bone axis via intestinal tuft cell expansion and butyrate signaling, showing promise for osteoimmunology and metabolic research. APExBIO offers a research-grade product with high purity and reproducibility.

• Mouse Neutrophil Cell Isolation Kit: High-Purity Immunothera

  2026-07-21

  Unlock streamlined, activation-free isolation of mouse neutrophils for advanced immunotherapy and mRNA nanovaccine research. This guide fuses state-of-the-art reference science with hands-on troubleshooting and protocol optimization for the Mouse Neutrophil Cell Isolation Kit (Negative Selection).

• Calpain Inhibitor I, ALLN: Technical Guidance for Research U

  2026-07-21

  Calpain Inhibitor I, ALLN (SKU A2602) provides selective and potent inhibition of calpain I/II and cathepsins B/L, supporting reproducible apoptosis assays and ischemia-reperfusion models. It is not intended for diagnostic or clinical use, and strict adherence to solubility and storage guidelines is critical. This guide outlines practical parameters and troubleshooting steps to maximize research reliability.

• Strategic Use of PX-478 2HCl: Advancing Hypoxia Pathway Rese

  2026-07-20

  This thought-leadership article explores the mechanistic foundations and translational applications of PX-478 2HCl, a potent HIF-1α inhibitor. Drawing on recent breakthroughs in sepsis-induced kidney injury and cancer radiosensitization, it provides actionable insights for researchers leveraging hypoxia signaling modulation in both oncology and inflammation models. The discussion integrates protocol guidance, competitive differentiation, and a critical outlook on cross-domain opportunities, positioning PX-478 2HCl as an indispensable asset for forward-thinking translational scientists.

16951 records 1/1131 page Next 12345 下5页 Last page